VESSINAT FEMME
Food supplement declared in France, declaration No 2018-3-398, decision dated 9 March 2018
VESSINAT FEMME, from LAB NAT, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Cucurbita pepo 425 mg per day, Glycine max. 75 mg per day, Triglycérides à chaine moyenne. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- LAB NAT
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 comprimé
- Directions for use
- 1 comprimé le matin, à prendre avec un verre d'eau
- Intended populations
- People over 60, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, History of breast cancer, Young children (aged 1 to 3), Pregnant women, Infants (under 1 year)
- Objectives stated by the manufacturer (these are not authorised claims)
- Urinary system
Declaration 287039, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cucurbita pepo L. | Graine | Extrait sec hydroalcoolique | 425 mg |
| Glycine max. (L.) Merr. | Graine | Extrait sec hydroalcoolique | 75 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Triglycérides à chaine moyenne | not declared |
Additives
E504, E460, E341, E553b, E470b, E468, E464, E170, E1200, E120
Other ingredients
maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière conseillée. Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne pas être utilisés comme substituts d'un régime alimentaire varié et équilibré. Déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein. Réservé à l'adulte. Déconseillé aux femmes enceintes ou allaitantes. A conserver dans un endroit sec, tempéré et à l'abri de la lumière.
Regulatory points
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycine max. (L.) Merr.
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “VESSINAT FEMME: composition and regulation”, https://compoatlas.com/en/supplements/products/287039-vessinat-femme, updated 15 November 2026.